Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.

about

Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.

Item

http://www.wikidata.org/entity/Q37402532

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@en

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@nl

type

Item

label

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@en

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@nl

prefLabel

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@en

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@nl

P1476

Degradable emulsion as vaccine ...... ameliorates vaccine efficacy.

@en

P2093

Chih-Hsiang Leng

http://www.w3.org/2001/XMLSchema#string

Chih-Ping Cheng

http://www.w3.org/2001/XMLSchema#string

Chiung-Yi Huang

http://www.w3.org/2001/XMLSchema#string

Chung-Hsiung Huang

http://www.w3.org/2001/XMLSchema#string

Ming-Hsi Huang

http://www.w3.org/2001/XMLSchema#string

Pele Chong

http://www.w3.org/2001/XMLSchema#string

Shih-Hsiung Dai

http://www.w3.org/2001/XMLSchema#string

Shih-Jen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses

Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine.

Emulsion-based adjuvants for influenza vaccines.

Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Role of formulation vehicles in taxane pharmacology.

Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant.

Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.

Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.

Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy.

P2888

srep36732

P304

36732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP36732

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hsin-Wei Chen

P577

2016-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27827451

http://www.w3.org/2001/XMLSchema#string

P932

5101498

http://www.w3.org/2001/XMLSchema#string